The 23 most recent market catalysts affecting $MDT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 16, 2026
Corporate Catalyst
Neutral
Impact 65
FDA Clears Medtronic’s LigaSure RAS Maryland Jaw Device For Use With Hugo Robotic-Assisted Surgery System
Medtronic received FDA clearance for its LigaSure RAS Maryland jaw device, allowing its use with the Hugo robotic-assisted surgery (RAS) system. This is significant because it inte…
Sep 3, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Buy on Medtronic, Raises Price Target to $110
UBS analyst Priya Sachdeva has maintained a 'Buy' rating on Medtronic (MDT) and raised the price target from $100 to $110. This action signals increased confidence from a prominent…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 92
Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection
Medtronic (MDT) announced upbeat fiscal first-quarter results, surpassing consensus estimates for both revenue and adjusted earnings. This strong performance prompted management to…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
B of A Securities Maintains Buy on Medtronic, Raises Price Target to $110
BofA Securities analyst Bob Hopkins has maintained a 'Buy' rating on Medtronic (MDT) and raised the price target from $95 to $110. This upgrade signals increased confidence from a …
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 85
Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings
Medtronic announced strong first-quarter results, surpassing analyst expectations for both earnings per share and revenue. This positive performance led the company to raise its fi…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Hold on Medtronic, Raises Price Target to $95
Stifel analyst Rick Wise maintained a 'Hold' rating on Medtronic (MDT) but raised the price target from $80 to $95. This action signals a more optimistic valuation for Medtronic by…
Sep 2, 2026
Market Technicals
Bearish
Impact 65
Dow Dips Over 400 Points As Crude Oil Surges: Investor Sentiment Weakens Further, Fear & Greed Index Moves To ‘Fear’ Zone
The market experienced a notable decline, with the Dow dropping over 400 points, primarily due to surging crude oil prices and rising Treasury yields. This confluence of factors in…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 55
BTIG Maintains Buy on Medtronic, Raises Price Target to $100
BTIG analyst Ryan Zimmerman maintained a 'Buy' rating on Medtronic and raised the price target from $91 to $100. This analyst action signals continued confidence in Medtronic's fut…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 92
Medtronic Unleashes $780 Million Deal Spree After Strong Quarter
Medtronic's Q1 fiscal 2027 performance exceeded expectations across the board, driven by broad-based portfolio growth, particularly in Cardiovascular and Diabetes. This strong oper…
Sep 1, 2026
Corporate Catalyst
Bearish
Impact 92
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
The filing primarily highlights Medtronic's strong Q1 performance, beating analyst estimates for both earnings and sales, and its decision to raise FY27 adjusted EPS guidance. This…
Sep 1, 2026
Corporate Catalyst
Neutral
Impact 75
Conference Call:
Medtronic Sees Q2 Adj EPS $1.32-$1.34 vs $1.34 Est
Medtronic's 8-K filing discloses its Q2 adjusted EPS guidance, which is projected to be between $1.32 and $1.34. This range is either slightly below or at the lower end of the anal…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 85
Medtronic shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 adjusted EPS guidance. Also, the company announced a $700 million strategic partnership with Cornerstone Robotics to expand global access to its Sentire Surgical System in select non-U.S. markets.
This headline represents a significant positive catalyst for Medtronic. The combination of strong financial performance exceeding expectations and a raised earnings outlook signals…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 75
Medtronic Announces $700M Strategic Partnership With Cornerstone Robotics To Expand Global Access To Sentire Surgical System In Select Non-U.S. Markets
Medtronic announced a $700 million strategic partnership with Cornerstone Robotics, securing distribution rights for the Sentire surgical system in certain international markets. T…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 85
Medtronic Q1 Adj. EPS $1.45 Beats $1.39 Estimate, Sales $9.756B Beat $9.545B Estimate
Medtronic announced its first-quarter earnings, revealing adjusted EPS of $1.45 and sales of $9.756 billion, both surpassing analyst consensus estimates. This performance represent…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 60
Medtronic Invests In Pi-Cardia To Accelerate Innovation For Complex Transcatheter Aortic Valve Replacement Patients And Procedures
Medtronic's strategic investment in Pi-Cardia Ltd. provides them with an option to enhance their structural heart portfolio, specifically in the complex and growing Transcatheter A…
Aug 31, 2026
Corporate Catalyst
Neutral
Impact 55
How To Earn $500 A Month From Medtronic Stock Ahead Of Q1 Earnings
The filing primarily focuses on Medtronic (MDT) ahead of its Q1 earnings report. A TD Cowen analyst maintained a 'Buy' rating and raised the price target from $100 to $110, indicat…
Aug 28, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on Medtronic, Raises Price Target to $110
TD Cowen analyst Joshua Jennings maintained a 'Buy' rating on Medtronic (MDT) and raised the price target from $100 to $110. This action signals increased confidence from the analy…
Aug 28, 2026
Corporate Catalyst
Bearish
Impact 65
Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
The filing details Medtronic's upcoming earnings report, scheduled for September 1st, and provides consensus estimates for quarterly EPS ($1.39) and revenue ($9.54 billion). This i…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 55
Needham Maintains Buy on Medtronic, Raises Price Target to $114
Needham analyst Mike Matson has updated his outlook on Medtronic, raising the price target from $101 to $114 while keeping a 'Buy' rating. This action signals increased confidence …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 65
Medtronic Announces Expanded CE Mark Indication For Its Affera Mapping And Ablation System With Sphere-9 Catheter To Treat Ventricular Arrhythmias, Including Ventricular Tachycardia And Premature Ventricular Complexes
Medtronic announced that its Sphere-9 catheter, part of the Affera Mapping and Ablation System, received FDA Breakthrough Device Designation for treating ventricular arrhythmias. T…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
Shares of medical device and equipment companies are trading higher as investors assess the key takeaways from last week's financial results across the sector.
This headline indicates a positive corporate catalyst for the medical device and equipment sector. Strong financial results from key players suggest healthy demand for their produc…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 65
UBS Upgrades Medtronic to Buy, Raises Price Target to $100
UBS analyst Priya Sachdeva upgraded Medtronic's stock rating from Neutral to Buy and raised the price target from $85 to $100. This analyst action signals a more optimistic view on…
Jul 13, 2026
Corporate Catalyst
Bearish
Impact 65
Reported Earlier: FDA Announces Medtronic Recalls Certain Harmony Delivery Catheter System
Medtronic has initiated a recall of its Harmony Delivery Catheter System, as announced by the FDA. This recall stems from a manufacturing defect that could cause the bond between t…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.